These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 7679553

  • 1. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
    Kamel OW, Gelb AB, Shibuya RB, Warnke RA.
    Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
    [Abstract] [Full Text] [Related]

  • 2. Coexistence of nodular lymphocyte predominance Hodgkin's disease and Hodgkin's disease of the usual type.
    Gelb AB, Dorfman RF, Warnke RA.
    Am J Surg Pathol; 1993 Apr; 17(4):364-74. PubMed ID: 8494105
    [Abstract] [Full Text] [Related]

  • 3. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
    Rysenga E, Linden MD, Carey JL, Ross CW, Schnitzer B, Sawdyk M, Maeda K.
    Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin's disease: a comparative immunohistochemical study.
    Nguyen PL, Ferry JA, Harris NL.
    Am J Surg Pathol; 1999 Jan; 23(1):27-33. PubMed ID: 9888701
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry.
    Rüdiger T, Ott G, Ott MM, Müller-Deubert SM, Müller-Hermelink HK.
    Am J Surg Pathol; 1998 Oct; 22(10):1184-91. PubMed ID: 9777980
    [Abstract] [Full Text] [Related]

  • 8. Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis.
    Kraus MD, Haley J.
    Am J Surg Pathol; 2000 Aug; 24(8):1068-78. PubMed ID: 10935647
    [Abstract] [Full Text] [Related]

  • 9. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study.
    Nguyen DT, Diamond LW, Hansmann ML, Fischer R.
    Hematopathol Mol Hematol; 1996 Aug; 10(3):135-50. PubMed ID: 8878732
    [Abstract] [Full Text] [Related]

  • 10. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J, Vandenberghe E, Kennes C, Verhoef G, Foschini MP, Stul M, Cassiman JJ, De Wolf-Peeters C.
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Nodular lymphocyte predominance Hodgkin's disease and its differential diagnosis].
    Carbonnelle A, Delarue R, Canioni D, Brousse N.
    Ann Pathol; 2004 Apr; 24(2):136-48; quiz 135. PubMed ID: 15220833
    [Abstract] [Full Text] [Related]

  • 13. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
    Churchill HR, Roncador G, Warnke RA, Natkunam Y.
    Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.
    Nam-Cha SH, Montes-Moreno S, Salcedo MT, Sanjuan J, Garcia JF, Piris MA.
    Mod Pathol; 2009 Aug; 22(8):1006-15. PubMed ID: 19465900
    [Abstract] [Full Text] [Related]

  • 16. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
    Elgin J, Phillips JG, Reddy VV, Gibbs PO, Listinsky CM.
    Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
    [Abstract] [Full Text] [Related]

  • 17. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
    Marafioti T, Mancini C, Ascani S, Sabattini E, Zinzani PL, Pozzobon M, Pulford K, Falini B, Jaffe ES, Müller-Hermelink HK, Mason DY, Pileri SA.
    Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Results of Southern blot analysis and polymerase chain reaction.
    Said JW, Sassoon AF, Shintaku IP, Kurtin PJ, Pinkus GS.
    Am J Pathol; 1991 Feb; 138(2):261-4. PubMed ID: 1899539
    [Abstract] [Full Text] [Related]

  • 20. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U, Herbst J, Metz KA, Leder LD.
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.